Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, et al. Obstet Gynecol 2022 Nov 3. pii: 00006250-990000000-00612.

Read + Share

Amedeo Smart

Independent Medical Education

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, et al. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstet Gynecol 2022 Nov 3. pii: 00006250-990000000-00612.
PMID: 36357960